Sumitomo Mitsui Trust Holdings, Inc. Organovo Holdings, Inc. Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	SELL	$1.41 - $2.17 $9,339 - $14,374	-6,624 Reduced 1.44%	454,752 $645,000
Q3 2022 Oct 21, 2022	SELL	$1.76 - $3.55 $5,368 - $10,827	-3,050 Reduced 0.66%	461,376 $946,000
Q2 2022 Jul 26, 2022	SELL	$1.71 - $3.71 $24,186 - $52,474	-14,144 Reduced 2.96%	464,426 $822,000
Q3 2020 Oct 30, 2020	BUY	$6.27 - $15.8 $3 Million - $7.56 Million	478,570 New	478,570 $3.79 Million

2.44M

17K

Ticker ONVO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,712,020
Market Cap $2.96M
Description
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.